Integration of transcriptomics, proteomics and loss-of-function screening reveals WEE1 as a target for combination with dasatinib against proneural glioblastoma
转录组学、蛋白质组学和功能缺失筛选的整合分析表明,WEE1 可作为与达沙替尼联合治疗神经前体胶质母细胞瘤的靶点。
期刊:Cancer Letters
影响因子:10.1
doi:10.1016/j.canlet.2024.217265
Alhalabi, Obada T; Göttmann, Mona; Gold, Maxwell P; Schlue, Silja; Hielscher, Thomas; Iskar, Murat; Kessler, Tobias; Hai, Ling; Lokumcu, Tolga; Cousins, Clara C; Herold-Mende, Christel; Heßling, Bernd; Horschitz, Sandra; Jabali, Ammar; Koch, Philipp; Baumgartner, Ulrich; Day, Bryan W; Wick, Wolfgang; Sahm, Felix; Krieg, Sandro M; Fraenkel, Ernest; Phillips, Emma; Goidts, Violaine